InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare.
The post Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success appeared first on InvestorPlace.
More From InvestorPlace